Nanotechnology Principles in Drug Targeting and Diagnosis

Mahendra Rai is an internationally recognized scholar with extensive contributions to microbial biotechnology and nanobiotechnology research, particularly in the green synthesis of metal nanoparticles using fungi and their application as nano‑antimicrobials. His work is highly interdisciplinary, bridging microbiology, biotechnology, and nanoscience, and he is an active member of several scientific societies. He has received multiple national and international distinctions, including the Father T.A. Mathias Award from the All-India Association for Christian Higher Education and the Medini Award from the Government of India. Professor Rai has also held numerous visiting scientist and visiting professor positions across Europe, South America, and Asia, contributing to long‑standing research collaborations in countries such as Brazil, Argentina, Hungary, Switzerland, Italy, Germany, and the United States. His sustained academic impact is reflected in his inclusion among the global top 2% of scientists in nanoscience and nanotechnology, and recognition as one of India’s leading researchers in biology and biochemistry, including a Biology and Biochemistry India Leader Award from Research.com. Shagufta Khan is Professor in the Department of Pharmaceutics, Institute of Pharmaceutical Education and Research, Borgaon, India. Her areas of research are the development of drug loaded nanocarriers, nasal drug delivery for brain targeting, stability enhancement of hygroscopic and photosensitive drugs, oral controlled drug delivery systems and rapid disintegrating tablets. Aarti Belgamwar is Assistant Professor in the in Shri Vile Parle Kelvani Mandal’s Institute of Pharmacy, Dhule. India. Her research interests are nasal drug delivery for brain targeting, solubility enhancement, polymer modification,oral controlled drug delivery systems, and development of multi-particulate drug delivery system.

• SECTION 1 Drug Targeting: General Principles and Strategies1. Drug Targeting: Nanotechnology Principles, Future Perspectives and Challenges2. Identifying Nanocarrier-Target Interaction3. Artificial Neural Network Based Inference of Drug - Target Interactions4. Macrophage-Mimetic Nanomedicines for the Treatment of Diseases5. Biopolymer Based Nanosystem for Drug Targeting6. Pharmacokinetics of NanomedicineSECTION 2 Nanotechnology Approaches for Organ/Disease Specific Targeting7. Targeted Breast Cancer Treatment: Progress and Challenges8. Nanotechnology Advances for Improved Targeting of Solid Tumors9. Solid Lipid Nanoparticles: The enhanced and targeted potential treatment of colorectal cancer10. Targeted Therapy for Aggressive Lung Cancer11. Molecular Targets for the Treatment of Angina Pectoris12. Nanocarriers: The enhanced potential treatment of age-related macular degeneration13. Nanotechnology Based Drug Targeting to Infectious Diseases14. Nanotechnological strategies for drug delivery and treatment of COVID-19SECTION 3 Nanotechnology Based Techniques for Medical Diagnosis15. Nanotechnological tools for the diagnosis and treatment of cancer16. Nanodiagnostics and Targeted Drug Delivery: Integrated Technologies17. Classification of clinically actionable Genetic Mutations in cancer patients using ML based precision diagnostics18. Nanotheranostic Applications in the Detection and Treatment of Cervical Cancer